Type 2 diabetes is a condition in which a person’s pancreas does not produce enough insulin, or the insulin produced does not work properly.
The function of insulin is to control the level of sugar in the blood, so if it is unable to do its job, blood sugar levels will be too high.
This is dangerous as it can lead to a number of complications involving the heart, nerves, eyes, kidneys and feet.
People with type 2 diabetes must therefore take action to control it, in order to prevent further health problems from occurring.
Oxford Biodynamics PLC (LON:OBD) was spun out from Oxford University in June 2007 with the aim of translating fundamental scientific advances into a commercialised platform technology and a new generation of biomarkers for cancer and other diseases including ALS.